Is the decision on the use of biosimilar growth hormone based on high quality scientific evidence? – a systematic review Linda FryklundMartin RitzénMarianne Heibert Arnlind Review Article 26 February 2014 Pages: 509 - 517
Sex as a variable in medicines assessment reports for licensing in the European Union. Can gender bias be excluded? N. Laguna-GoyaF. de Andres-Trelles Clinical Trial 11 February 2014 Pages: 519 - 525
Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarction Kian-Keong PohXin XuMing-He Huang Clinical Trial 25 January 2014 Pages: 527 - 530
Multitargeted antiangiogenic tyrosine kinase inhibitors combined to chemotherapy in metastatic breast cancer: a systematic review and meta-analysis Zexing WangMeiqi WangXiaoxiang Guan Clinical Trial 23 February 2014 Pages: 531 - 538
Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2 Marco FerrariLuigina GuastiMarco Cosentino Pharmacogenetics 06 March 2014 Pages: 539 - 547
The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration Claire JohnstonSarah N. HilmerCarl M. Kirkpatrick Pharmacokinetics and Disposition 14 February 2014 Pages: 549 - 555
Trends in statin therapy initiation during the period 2000–2010 in Israel Varda ShalevClara WeilGabriel Chodick Pharmacoepidemiology and Prescription 25 January 2014 Pages: 557 - 564
Inappropriate crushing information on ward lists: cytotoxic drugs, capsules, and modified release formulations are gravely neglected Kristina LohmannJulia FerberHanna Marita Seidling Pharmacoepidemiology and Prescription 28 January 2014 Pages: 565 - 573
Prevalence of polypharmacy in a Scottish primary care population R. A. PayneA. J. AveryG. A. Abel Pharmacoepidemiology and Prescription 01 February 2014 Pages: 575 - 581
Exploring the perspectives of potential consumers and healthcare professionals on the readability of a package insert: a case study of an over-the-counter medicine Carla M. PiresAfonso M. Cavaco Pharmacoepidemiology and Prescription 24 January 2014 Pages: 583 - 588
Influence of refill adherence method when comparing level of adherence for different dosing regimens A. K. JönssonL. SchiölerA-C Mårdby Pharmacoepidemiology and Prescription 13 February 2014 Pages: 589 - 597
Prevalence of potentially inappropriate prescribing and prescribing omissions in older Irish adults: findings from The Irish LongituDinal Study on Ageing study (TILDA) Rose GalvinFrank MoriartyRose-Anne Kenny Pharmacoepidemiology and Prescription Open access 04 February 2014 Pages: 599 - 606
A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions Nataporn ChaipichitJanet KrskaNarumol Jarernsiripornkul Pharmacoepidemiology and Prescription 16 February 2014 Pages: 607 - 615
Pharmacological prioritisation of signals of disproportionate reporting: proposal of an algorithm and pilot evaluation Francesco SalvoEmanuel RaschiAntoine Pariente Pharmacoepidemiology and Prescription 05 March 2014 Pages: 617 - 625
Reducing the noise in signal detection of adverse drug reactions by standardizing the background: a pilot study on analyses of proportional reporting ratios-by-therapeutic area Birgitta GrundmarkLars HolmbergBjörn Zethelius Pharmacoepidemiology and Prescription Open access 07 March 2014 Pages: 627 - 635